CEACAM5 and neoplasm: Protein tumor markers in the blood, such as carcinoembryonic antigen (CEA), cancer antigen 15-3 (CA15-3), and cancer antigen 19-9 (CA19-9), among others, are routinely used as prognosis biomarkers or cancer surveillance and monitoring response [12].